Skip to main content
Have a personal or library account? Click to login
Mitochondrial genome aberrations in canine spleen tumours* Cover

Mitochondrial genome aberrations in canine spleen tumours*

Open Access
|Jun 2026

References

  1. Aronsohn M.G., Dubiel B., Roberts B., Powers B.E. (2009). Prognosis for acute nontraumatic hemoperitoneum in the dog: a retrospective analysis of 60 cases (2003–2006). J. Am. Anim. Hosp. Assoc., 45: 72–77.
  2. Baranowska I., Jaderlund K.H., Nennesmo I., Holmqvist E., Heidrich N., Larsson N.G., Andersson G., Wagner E.G., Hedhammar A., Wibom R., Andersson L. (2009). Sensory ataxic neuropathy in golden retriever dogs is caused by a deletion in the mitochondrial tRNATyr gene. PLoS Genet., 5: e1000499.
  3. Bertagnolli A.C., Soares P., van Asch B., Amorim A., Cirnes L., Maximo V., Cassali G.D. (2009). An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis. Vet. J., 182: 269–274.
  4. Brigandi E., Valenti P., Bacci B., Brunetti B., Avallone G. (2024). Prognostic impact of Ki-67 in canine splenic hemangiosarcoma: A preliminary study. Vet. Pathol., 61: 534–540.
  5. Combet C., Blanchet C., Geourjon C., Deléage G. (2000). NPS@: network protein sequence analysis. Trends Biochem. Sci., 3: 147–150.
  6. Davies O., Taylor A.J. (2020). Refining the “double two-thirds” rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs. Vet. Comp. Oncol., 18: 548–558.
  7. De Nardi A.B., de Oliveira Massoco Salles Gomes C., Fonseca-Alves C.E., de Paiva F.N., Linhares L.C.M., Carra G.J.U., Dos Santos Horta R., Ruiz Sueiro F.A., Jark P.C., Nishiya A.T., de Carvalho Vasconcellos C.H., Ubukata R., Batschinski K., Sobral R.A., Fernandes S.C., Biondi L.R., De Francisco Strefezzi R., Matera J.M., Rangel M.M.M., Dos Anjos D.S., Brunner C.H.M., Laufer-Amorim R., Cadrobbi K.G., Cirillo J.V., Martins M.C., de Paula Reis Filho N., Silva Lessa D.F., Portela R., Scarpa Carneiro C., Ricci Lucas S.R., Fukumasu H., Feliciano M.A.R., Gomes Quitzan J., Dagli M.L.Z. (2023). Diagnosis, prognosis, and treatment of canine hemangiosarcoma: A review based on a consensus organized by the Brazilian Association of Veterinary Oncology, ABROVET. Cancers, 15.
  8. de Oliveira R.C., Dos Reis S.P., Cavalcante G.C. (2023). Mutations in structural genes of the mitochondrial complex IV may influence breast cancer. Genes, 14.
  9. den Dunnen J.T., Dalgleish R., Maglott D.R., Hart R.K., Greenblatt M.S., McGowan-Jordan J., Roux A.F., Smith T., Antonarakis S.E., Taschner P.E. (2016). HGVS recommendations for the description of sequence variants: 2016 update. Hum. Mutat., 37: 564–569.
  10. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch A. (2003). ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res., 31: 3784–3788.
  11. Geourjon C., Deleage G. (1995). SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinformatics, 11: 681–684.
  12. Gorelick A.N., Kim M., Chatila W.K., La K., Hakimi A.A., Berger M.F., Taylor B.S., Gammage P.A., Reznik E. (2021). Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA. Nat. Metab., 3: 558–570.
  13. Griffin M.A., Culp W.T.N., Rebhun R.B. (2021). Canine and feline haemangiosarcoma. Vet. Rec., 189: e585.
  14. Gustafson D.L., Duval D.L., Regan D.P., Thamm D.H. (2018). Canine sarcomas as a surrogate for the human disease. Pharmacol. Ther., 188: 80–96.
  15. Hahn A., Zuryn S. (2019). Mitochondrial genome (mtDNA) mutations that generate reactive oxygen species. Antioxidants, 8.
  16. Hamid K.S., Rodriguez J.A., Lairmore T.C. (2010). Primary splenic angiosarcoma. JSLS, 14: 431–435.
  17. Hendrick M.J. (2016). Tumors in domestic animals, Meuten D.J. (ed.). John Wiley & Sons, Wiley Blackwell, Iowa, pp. 142–175.
  18. Imes D.L., Wictum E.J., Allard M.W., Sacks B.N. (2012). Identification of single nucleotide polymorphisms within the mtDNA genome of the domestic dog to discriminate individuals with common HVI haplotypes. Forensic Sci. Int. Genet., 6: 630–639.
  19. Kabekkodu S.P., Bhat S., Mascarenhas R., Mallya S., Bhat M., Pandey D., Kushtagi P., Thangaraj K., Gopinath P.M., Satyamoorthy K. (2014). Mitochondrial DNA variation analysis in cervical cancer. Mitochondrion, 16: 73–82.
  20. Kapturska K.M., Pawlak A. (2023). New molecular targets in canine hemangiosarcoma – Comparative review and future of the precision medicine. Vet. Comp. Oncol., 21: 357–377.
  21. Kim J.H., Graef A.J., Dickerson E.B., Modiano J.F. (2015). Pathobiology of hemangiosarcoma in dogs: Research advances and future perspectives. Vet. Sci., 2: 388–405.
  22. Kim K.S., Lee S.E., Jeong H.W., Ha J.H. (1998). The complete nucleotide sequence of the domestic dog (Canis familiaris) mitochondrial genome. Mol. Phylogenet. Evol., 10: 210–220.
  23. Kim M., Mahmood M., Reznik E., Gammage P.A. (2022). Mitochondrial DNA is a major source of driver mutations in cancer. Trends Cancer, 8: 1046–1059.
  24. Kopinski P.K., Singh L.N., Zhang S., Lott M.T., Wallace D.C. (2021). Mitochondrial DNA variation and cancer. Nat. Rev. Cancer., 21: 431–445.
  25. Kowal K., Tkaczyk-Wlizlo A., Pierzchala M., Gawor J., Slaska B. (2022). Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours. Vet. Comp. Oncol., 20: 256–264.
  26. Li F.Y., Cuddon P.A., Song J., Wood S.L., Patterson J.S., Shelton G.D., Duncan I.D. (2006). Canine spongiform leukoencephalomyelopathy is associated with a missense mutation in cytochrome b. Neurobiol. Dis., 21: 35–42.
  27. Magas M., Szczepańska K., Jankowski M., Bukowska D., Antosik P. (2018). Splenic leiomyoma in dog. Med. J. Cell Biol., 6: 8–12.
  28. Megquier K., Turner-Maier J., Swofford R., Kim J.-H., Sarver A.L., Wang C., Sakthikumar S., Johnson J., Koltookian M., Lewellen M., Scott M.C., Graef A.J., Borst L., Tonomura N., Alfoldi J., Painter C., Thomas R., Karlsson E.K., Breen M., Modiano J.F., Elvers I., Lindblad-Toh K. (2019). Genomic analysis reveals shared genes and pathways in human and canine angiosarcoma. Mol. Cancer Res., 17: 2410–2421.
  29. O’Byrne K., Hosgood G. (2019). Splenic mass diagnosis in dogs undergoing splenectomy according to breed size. Vet. Rec., 184: 620.
  30. Okonechnikov K., Golosova O., Fursov M., team U. (2012). Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics, 28: 1166–1167.
  31. Paciello O., Maiolino P., Fatone G., Papparella S. (2003). Mitochondrial myopathy in a German Shepherd dog. Vet. Pathol., 40: 507–511.
  32. Shelton G.D., Mickelson J.R., Friedenberg S.G., Cullen J.N., Mehra J.M., Guo L.T., Minor K.M. (2024). Multi-allelic mitochondrial DNA deletions in an adult dog with chronic weakness, exercise intolerance and lactic acidemia. Animals, 14.
  33. Sobczynska-Rak A., Silmanowicz P., Sobolewska E. (2009). Angiogenesis in malignant spleen cancers in dogs (in Polish). Med. Wet., 10: 693–696.
  34. Story A.L., Wavreille V., Abrams B., Egan A., Cray M., Selmic L.E. (2020). Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma. Vet. Surg., 49: 1154–1163.
  35. Strakova A., Ni Leathlobhair M., Wang G.D., Yin T.T., Airikkala-Otter I., Allen J.L., Allum K.M., Bansse-Issa L., Bisson J.L., Castillo Domracheva A., de Castro K.F., Corrigan A.M., Cran H.R., Crawford J.T., Cutter S.M., Delgadillo Keenan L., Donelan E.M., Faramade I.A., Flores Reynoso E., Fotopoulou E., Fruean S.N., Gallardo-Arrieta F., Glebova O., Hafelin Manrique R.F., Henriques J.J., Ignatenko N., Koenig D., Lanza-Perea M., Lobetti R., Lopez Quintana A.M., Losfelt T., Marino G., Martincorena I., Martinez Castaneda S., Martinez-Lopez M.F., Meyer M., Nakanwagi B., De Nardi A.B., Neunzig W., Nixon S.J., Onsare M.M., Ortega-Pacheco A., Peleteiro M.C., Pye R.J., Reece J.F., Rojas Gutierrez J., Sadia H., Schmeling S.K., Shamanova O., Ssuna R.K., Steenland-Smit A.E., Svitich A., Thoya Ngoka I., Vitalaru B.A., de Vos A.P., de Vos J.P., Walkinton O., Wedge D.C., Wehrle-Martinez A.S., van der Wel M.G., Widdowson S.A., Murchison E.P. (2016). Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer. eLife, 5.
  36. Sun W., Zhou S., Chang S.S., McFate T., Verma A., Califano J.A. (2009). Mitochondrial mutations contribute to HIF1α accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma. Clin. Cancer Res., 15: 476–484.
  37. Ślaska B., Surdyka M., Brodzki A., Nisztuk S., Gurgul A., Bugno-Poniewierska M., Śmiech A., Różańska D., Orzelski M. (2014). Mitochondrial D-loop mutations can be detected in sporadic malignant tumours in dogs. Bull. Vet. Inst. Pulawy, 58: 631–637.
  38. Ślaska B., Grzybowska-Szatkowska L., Bugno-Poniewierska M., Gurgul A., Śmiech A., Różanska D., Dudka J. (2016). Relevance of molecular changes in the ND4 gene in German Shepherd dog tumours. Pol. J. Vet. Sci., 19: 461–469.
  39. Śmiech A., Ślaska B., Bownik A., Grzybowska-Szatkowska L., Dudka J., Łopuszyński W. (2019). Heteroplasmic mutations and polymorphisms in the cyb gene of mitochondrial DNA in canine mast cell tumours. In Vivo, 33: 57–63.
  40. Tkaczyk-Wlizlo A., Kowal K., Ślaska B. (2024). Whole mitochondrial genome sequencing analysis of canine testicular tumours. Int. J. Mol. Sci., 25: 9944.
  41. Varela B., Larrañaga C., Yamasaki K., Verdes J.M. (2022). Canine splenic tumors: Histopathological study of 9 cases in Uruguay, 2019–2020. Braz. J. Vet. Pathol., 15: 127–132.
  42. Vaser R., Adusumalli S., Leng S.N., Sikic M., Ng P.C. (2016). SIFT missense predictions for genomes. Nat. Protoc., 11: 1–9.
  43. Wang G., Wu M., Maloneyhuss M.A., Wojcik J., Durham A.C., Mason N.J., Roth D.B. (2017). Actionable mutations in canine hemangiosarcoma. PLoS One, 12: e0188667.
  44. Wang G., Wu M., Durham A.C., Radaelli E., Mason N.J., Xu X., Roth D.B. (2020). Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma. PLoS One, 15: e0229728.
DOI: https://doi.org/10.2478/aoas-2026-0002 | Journal eISSN: 2300-8733 (formerly 1642-3402) | Journal ISSN: 1642-3402
Language: English
Submitted on: Jun 6, 2025
Accepted on: Dec 1, 2025
Published on: Jun 5, 2026
Published by: National Research Institute of Animal Production
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2026 Angelika Tkaczyk-Wlizło, Krzysztof Kowal, Anna Śmiech, Brygida Ślaska, published by National Research Institute of Animal Production
This work is licensed under the Creative Commons Attribution 4.0 License.